NCT04984200View on ClinicalTrials.gov

Assessment of EyeArt Performance With Retinal Cameras

CompletedOBSERVATIONAL
Enrollment

246

Participants

Timeline

Start Date

July 13, 2021

Primary Completion Date

August 19, 2022

Study Completion Date

August 19, 2022

Conditions
Diabetic Retinopathy
Interventions
PROCEDURE

Retinal imaging

Subjects will undergo retinal imaging before and/or after administration of mydriatic agent

DRUG

Mydriatic Agent

Subjects will be administered mydriatic medication to dilate their pupils.

Trial Locations (1)

83404

Rocky Mountain Diabetes Center, Idaho Falls

All Listed Sponsors
lead

Eyenuk, Inc.

INDUSTRY